# Sonidegib Phosphate (Odomzo)

Source: https://ourhealthnetwork.com/drugs/sonidegib-phosphate
Data: FDA Orange Book and OpenFDA, refreshed periodically

## What is Sonidegib Phosphate?

Sonidegib Phosphate (brand name: Odomzo) is a hedgehog pathway inhibitor. It is prescribed to treat skin neoplasms. Across the United States, 58 doctors prescribe Sonidegib to approximately 20 Medicare patients.

## Brand names

Odomzo

## Indications

Sonidegib Phosphate is primarily prescribed for the treatment of skin neoplasms.

## Conditions treated

- [Skin Neoplasms](https://ourhealthnetwork.com/conditions/skin-neoplasms)

## Mechanism of action

Sonidegib is an inhibitor of the Hh pathway. Sonidegib binds to and inhibits Smoothened, a transmembrane protein involved in Hh signal transduction.

## Drug classification

- Established Pharmacologic Class: hedgehog pathway inhibitors
- Route of administration: ORAL

## Common side effects

or topical or photodynamic therapies, radiotherapy, systemic chemotherapy

## Sources and disclaimers

- FDA Orange Book and OpenFDA dataset
- This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting, stopping, or changing any medication.

## Related

- [All drugs](https://ourhealthnetwork.com/drugs)
- [Find specialists who prescribe this drug](https://ourhealthnetwork.com/find-doctors)
- [Methodology](https://ourhealthnetwork.com/methodology)